Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Cars.com
CARS
5
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US OptionsDetailed Quotes
BPMC250417C95000
- 2.05
- 0.000.00%
15min DelayClose Apr 4 16:00 ET
0.00High0.00Low
2.05Open2.05Pre Close0 Volume1.65K Open Interest95.00Strike Price0.00Turnover88.87%IV18.82%PremiumApr 17, 2025Expiry Date0.00Intrinsic Value100Multiplier11DDays to Expiry2.05Extrinsic Value100Contract SizeAmericanOptions Type0.1944Delta0.0212Gamma62.83Leverage Ratio-0.1548Theta0.0047Rho12.21Eff Leverage0.0402Vega
Blueprint Medicines Newsroom
The "Liberation Day" of Trump's tariffs is approaching, and the pharmaceutical Industry may not be among the targets.
According to reports, President Trump of the USA is expected to announce a series of broader tariff measures on local time April 2 (Wednesday), which will not include any specific details on Pharmaceutical tariffs.
Wolfe Research Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $132
Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference
Blueprint Medicines Corporation's (NASDAQ:BPMC) Shift From Loss To Profit
THE PROLIFT RIGGING COMPANY LAUNCHES STRATEGIC PARTNERSHIP WITH BLUEPRINT SUPPLY CHAIN TO AID DATA CENTER CONSTRUCTION
Is Blueprint Medicines Corporation (BPMC) a Promising Biotech Stock According to Wall Street Analysts
The Analyst Verdict: Blueprint Medicines In The Eyes Of 14 Experts
Blueprint Medicines (BPMC): Among Stocks Insiders Are Selling In March
Morgan Stanley Assumes Blueprint Medicines at Equal-Weight, Lowers Price Target of $100
Morgan Stanley Initiates Blueprint Medicines(BPMC.US) With Hold Rating, Announces Target Price $100
Balanced Outlook on Blueprint Medicines: Growth Prospects and Market Dynamics
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Piper Sandler Initiates Blueprint Medicines(BPMC.US) With Hold Rating, Announces Target Price $119
Wolfe Research Initiates Blueprint Medicines(BPMC.US) With Buy Rating, Announces Target Price $132
Director's Major Stock Sale Shakes Up Blueprint Medicines!
Blueprint Medicines Initiated With an Outperform at Wolfe Research
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Blueprint Medicines Price Target Announced at $135.00/Share by Jefferies
Jefferies Initiates Blueprint Medicines(BPMC.US) With Buy Rating, Announces Target Price $135
Express News | Scotiabank Initiates Coverage On Blueprint Medicines With Sector Outperform Rating, Announces Price Target of $150
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now